BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8093129)

  • 1. On the catastrophic adjective for the antiphospholipid syndrome.
    Alarcon-Segovia D
    Clin Exp Rheumatol; 1993; 11(6):587-8. PubMed ID: 8093129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Classification criteria for the antiphospholipid syndrome--the next modification].
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2006 May; 115(5):396-400. PubMed ID: 17195350
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.
    Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR
    Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055
    [No Abstract]   [Full Text] [Related]  

  • 4. Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid anti-bodies.
    Sangle SR; Jan W; Lau IS; Bennett AN; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2006; 24(3):349. PubMed ID: 16870110
    [No Abstract]   [Full Text] [Related]  

  • 5. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman.
    Mizuno R; Fujimoto S; Fujimoto T; Nishino T; Shiiki H; Hashimoto T; Nakamura S; Dohi K
    Intern Med; 2000 Oct; 39(10):856-9. PubMed ID: 11030215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and pathogenesis of catastrophic antiphospholipid syndrome.
    Kaburaki J
    Intern Med; 2000 Oct; 39(10):763-4. PubMed ID: 11030196
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies.
    Paira SO
    J Rheumatol; 1998 Dec; 25(12):2476-7. PubMed ID: 9858454
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression.
    Hess DC; Sethi K; Awad E
    J Rheumatol; 1992 Sep; 19(9):1474-8. PubMed ID: 1433020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
    Alekberova ZS; Nasonov EL; Stoianovich LZ
    Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
    Naarendorp M; Spiera H
    J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
    Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
    Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial antiphospholipid antibodies and acquired circulating anticoagulants.
    Elhajj I; Uthman I; Chahel A; Khoury F; Arayssi T; Taher A
    Lupus; 2004; 13(10):812-4. PubMed ID: 15540515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuro-ophthalmologic aspects in antiphospholipid syndrome].
    Roşca T; Bontaş E; Bartoş D
    Oftalmologia; 2004; 48(2):65-70. PubMed ID: 15341103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valvular heart disease and systemic lupus erythematosus.
    Piette JC; Amoura Z; Papo T
    N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132594
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
    Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
    J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid syndrome--the description of two cases].
    Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
    Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupoid sclerosis: what is the role of antiphospholipid antibodies?
    Lima I; Melo A; Brandi IV; Costa O; Santiago M
    J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?
    Laskin CA; Clark CA; Spitzer KA
    Rheum Dis Clin North Am; 2005 May; 31(2):255-72, vi. PubMed ID: 15922145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.